packageCasopitant

casopitant

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Casopitant is an investigational antiemetic (an NK1 receptor antagonist) studied for preventing nausea and vomiting, including postoperative nausea and vomiting and vomiting associated with cancer treatment. It was never marketed; its European Union marketing application was withdrawn, so it remains investigational.

Summary written by glm-5.3-flash from Wikidata Q5049003 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:casopitant
ATC codes:A04AD13
DrugBank:DB06634
PubChem CID:9917021
ChEBI:135967
Wikidata:Q5049003
formula:C30H35F7N4O2
molar mass:616.622 g/mol (PubChem CID 9917021)
logP:5.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown